Patent · US Active

Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity

US10562898B2 · kind B2 · utility

3Cited by

1References

20Claims

0Family size

Assignee

EA PHARMA CO., LTD. · JP

Inventors

Munetaka Tokumasu · Kawasaki, JP
Masatsugu Noguchi · Kawasaki, JP
Mizuki KAWAHIRA · Chuo, JP
Kana Iwasaki · Chuo, JP
Nobuhiko HAYAKAWA · Chuo, JP
Wataru Miyanaga · Kawasaki, JP
Yuki Saitou · Chuo, JP
Yui Yamaura · Chuo, JP
Ayatoshi Ando · Chuo, JP
Atsushi TSURUTA · Chuo, JP
Misato Noguchi · Chuo, JP

Key dates

Filing date	Feb 6, 2017
Grant date	Feb 18, 2020
Priority date	—
Expiry date	Feb 6, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/052
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is a compound having α4 integrin inhibitory action.The compound is a sulfonamide derivative represented by the following formula (I), or pharmaceutically acceptable salt thereof: where R1 to R5, e to h, D, and B represent those as described in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.